Home › NDC Lookup › RxCUI directory › RxCUI 2671298

Hydrocortisone 6.67 MG/ML / tolnaftate 10 MG/ML Topical Solution — RxCUI 2671298

RxNorm drug concept · Semantic clinical drug
RxCUI 2671298 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2671298
Official nameHydrocortisone 6.67 MG/ML / tolnaftate 10 MG/ML Topical Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashydrocortisone 0.667 % / tolnaftate 1 % Topical Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is used as add-on treatment for ulcerative colitis, especially when it affects the lower or left side of the colon. It is meant to be used along with other supportive measures y...
  • It's usually used once at night. Lie on your left side while you use it and for about 30 minutes after. Try to hold it in at least an hour, ideally all night. Your doctor may sugge...
  • How do I use it, and how long do I keep it in?
  • A usual course is about 21 days, or until you're in remission. Many people feel better within 3 to 5 days. If you use it longer, your doctor will taper you off to every other night...
📖 Read our full Hydrocortisone Rectal guide →

🕸️ Concept Web — How Hydrocortisone 6.67 MG/ML / tolnaftate 10 MG/ML... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydrocortisone 6.67 MG/ML / tolnaftate 10 MG/ML Topical Solution RxCUI 2671298

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Hydrocortisone 5492
    • Tolnaftate 10637
    • Hydrocortisone / tolnaftate 2671295
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydrocortisone / tolnaftate Topical Solution 2671297
    • Hydrocortisone / tolnaftate Topical Product 2671296
    • Topical Solution 316986
    • Topical Product 1151122
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Hydrocortisone 6.67 MG/ML 2671294
    • Tolnaftate 10 MG/ML 328892

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydrocortisone 6.67 MG/ML SCDC · 2671294
  • Tolnaftate 10 MG/ML SCDC · 328892
  • Hydrocortisone / tolnaftate Topical Solution SCDF · 2671297
  • Hydrocortisone / tolnaftate Topical Product SCDG · 2671296

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2671298 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59088-0264-03 30 mL in 1 BOTTLE (59088-264-03) Mycozyl HC PURETEK CORPORATION 2023-12-11
Observed labelers: PURETEK CORPORATION (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.